Ignite Creation Date:
2025-12-25 @ 12:39 AM
Ignite Modification Date:
2025-12-25 @ 10:50 PM
Study NCT ID:
NCT00975767
Status:
TERMINATED
Last Update Posted:
2015-01-08
First Post:
2009-09-10
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of MGCD265 Given With Erlotinib or Docetaxel in Subjects With Advanced Malignancies or Non-Small Cell Lung Cancer
Sponsor:
Mirati Therapeutics Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-08
Start Date Type:
None
Primary Completion Date:
2013-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-08
Completion Date Type:
ACTUAL
First Submit Date:
2009-09-10
First Submit QC Date:
None
Study First Post Date:
2009-09-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-01-06
Last Update Post Date:
2015-01-08
Last Update Post Date Type:
ESTIMATED